» Articles » PMID: 26439684

HIF2α is Involved in the Expansion of CXCR4-positive Cancer Stem-like Cells in Renal Cell Carcinoma

Overview
Journal Br J Cancer
Specialty Oncology
Date 2015 Oct 7
PMID 26439684
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypoxia and the subsequent activation of hypoxia-inducible factor-2α (HIF2α) contribute to the progression of a variety of cancers. However, their role in the generation of renal cell carcinoma-derived stem cells has not been fully addressed.

Methods: A sphere formation assay, cell proliferation, RT-PCR, western blot, FACS, immunohistochemistry and tumour xenograft were used to study the role of HIF2α.

Results: Propagation of four renal cell carcinoma (RCC) cell lines (Caki-1, Caki-2, 786-O, 769-P) in anchorage-independent floating spheres led to the expansion of cells bearing the CXCR4 (CD184) surface marker. Inhibition of the CXCR4 pathway reduced sphere expansion. The enhanced self-renewal activity of the CXCR4-positive spheres was preceded by the upregulation of HIF2α. Knockdown of HIF2α abrogated CXCR4 expression and sphere formation. Finally, RCC-derived spheres showed an undifferentiated phenotype in vivo and formed subcutaneous tumours that highly expressed HIF2α and CXCR4. Inhibition of HIF2α abolished tumour growth in animal models.

Conclusions: These results suggest that the generation of RCC-derived CSCs involves the activation of HIF2α and may provide a foundation for the development of new strategies to prevent the induction of CSCs in RCC.

Citing Articles

Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma.

Pham D, Hsu T J Biomed Sci. 2025; 32(1):17.

PMID: 39920694 PMC: 11806631. DOI: 10.1186/s12929-024-01111-9.


A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System.

Zhang D, Cai Y, Sun Y, Zeng P, Wang W, Wang W Front Pharmacol. 2025; 15:1442765.

PMID: 39741633 PMC: 11685139. DOI: 10.3389/fphar.2024.1442765.


Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer.

Bae T, Hallis S, Kwak M Exp Mol Med. 2024; 56(3):501-514.

PMID: 38424190 PMC: 10985007. DOI: 10.1038/s12276-024-01180-8.


Effect of preserved eggs on the health of SD rats, and anti-tumor action of HT-29 cells.

Wu Y, Mao C, Hu G, Ma L, Li S, Ma M Food Sci Nutr. 2023; 11(10):6188-6198.

PMID: 37823098 PMC: 10563691. DOI: 10.1002/fsn3.3558.


Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers.

Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo S, Crocetto F Int J Mol Sci. 2023; 24(17).

PMID: 37685983 PMC: 10487877. DOI: 10.3390/ijms241713179.


References
1.
Nakata S, Campos B, Bageritz J, Lorenzo Bermejo J, Becker N, Engel F . LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol. 2012; 23(1):60-72. PMC: 8028985. DOI: 10.1111/j.1750-3639.2012.00618.x. View

2.
Pan J, Zhang Q, Wang Y, You M . 26S proteasome activity is down-regulated in lung cancer stem-like cells propagated in vitro. PLoS One. 2010; 5(10):e13298. PMC: 2952619. DOI: 10.1371/journal.pone.0013298. View

3.
Kaur S, Singh G, Kaur K . Cancer stem cells: an insight and future perspective. J Cancer Res Ther. 2015; 10(4):846-52. DOI: 10.4103/0973-1482.139264. View

4.
Chiavarina B, Martinez-Outschoorn U, Whitaker-Menezes D, Howell A, Tanowitz H, Pestell R . Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells. Cell Cycle. 2012; 11(17):3280-9. PMC: 3466527. DOI: 10.4161/cc.21643. View

5.
Baldewijns M, van Vlodrop I, Vermeulen P, Soetekouw P, van Engeland M, de Bruine A . VHL and HIF signalling in renal cell carcinogenesis. J Pathol. 2010; 221(2):125-38. DOI: 10.1002/path.2689. View